NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NEPHROS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$3.68+0.03 (+0.82%)
Close on Oct 19, 2026
- Market cap
- $40.89M
- P/E (TTM)
- 23.0
- Dividend yield
- –
NEPHROS INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $5.70M | $5.04M | $4.62M | $4.60M | $4.31M | $4.71M | $3.85M | $3.47M | $3.21M | $3.51M | $3.20M | $3.71M | 94.7% | +32.2% |
| Service Royalty and Other Revenues [Member] | $316.00K | $172.00K | – | $168.00K | $108.00K | $171.00K | – | $46.00K | $44.00K | – | – | – | 5.3% | +192.6% |
| Royalty and Other Revenues [Member] | – | – | – | – | – | $171.00K | $21.00K | $46.00K | $44.00K | $16.00K | $56.00K | $29.00K | – | – |
| Royalty and Service Revenues [Member] | – | – | – | – | – | $171.00K | – | – | – | $16.00K | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Nephros's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.